Abstract

We report the case of a 61-year-old gentleman who underwent pericardiectomy for constrictive pericarditis. Constrictive pericarditis was diagnosed through echocardiogram, computed tomography chest and cardiac magnetic resonance imaging. An elective decision was made for commencing venoarterial extracorporeal membrane oxygenation (ECMO) immediately postoperatively to prevent significant right ventricular failure (RVF). Postoperatively, the patient remained on ECMO for 4 days in a stable condition, showing no further signs of RVF. Venoarterial ECMO may be of use as an elective adjunct in cases at high risk of RVF following pericardiectomy.

INTRODUCTION

Pericardiectomy for patients with constrictive pericarditis (CP) is not a commonly performed cardiac surgery operation, and there is limited experience in the management strategies [1]. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is a new method of providing cardiorespiratory mechanical support, with early reports indicating low thresholds in patients developing right ventricular failure (RVF) [2–4].

We report the case of a patient with CP at high risk of developing RVF postoperatively, who was placed electively on VA-ECMO in the immediate postoperative period.

CASE REPORT

The patient presented with worsening breathlessness, decreasing exercise tolerance capacity and weight loss. Medical history included severe pectus excavatum, with reduced left lung volume and mediastinal shift. He underwent a left pleural biopsy, which showed inflammatory changes, with no evidence of malignancy. CP was diagnosed through transthoracic echocardiogram, computed tomography chest and cardiac magnetic resonance imaging (MRI). The patient was considered to be at high risk for developing RVF postoperatively based on a combination of decreased preload (because of CP and the presence of pericardial effusion), a dilated right ventricle (assessed by MRI and tranoesophageal echocardiogram (TOE) parameters) and raised pulmonary vascular resistance (PVR) due to left lung collapse.

Transthoracic echocardiogram

The pericardium appeared bright and thickened. Pericardial collection was measured at 1.6 cm. Respiratory variation and flow reversal into the hepatic vein were noted. The inferior vena cava was normal in size, with <50% collapse changes.

Computed tomography chest

Widespread pleural and pericardial thickening was reported, alongside severe pectus excavatum contributing to the reduction in left thoracic volume.

Operation

ECMO cannulation was performed electively as a preoperative step via the left common femoral vein and right common femoral artery. A phrenic to phrenic excision extending to the diaphragm and neck vessels was performed. Once the constriction of the right ventricle and right atrium was released, these became distended with the elevated right atrial pressures, and the TOE demonstrated a transient deterioration in RV function. The RV dysfunction was quantified through the following parameters: (i) the dilated right ventricle—quantified by the right ventricle/left ventricle ratio = 1.2 (normal value ≤1); (ii) tricuspid annular plane systolic excursion (TAPSE) = 1 cm (normal >1.6 cm in ventilated or 2.4 cm in non-ventilated patients); (iii) a straight septum appearance in the end systole; and (iv) poor radial RV function. The right ventricular function was seen to progressively improve on TOE.

The patient remained on ECMO for 4 days postoperatively. Following successful weaning from ECMO, the decannulation was performed through a surgical cut-down and primary closure. Mildly deranged liver function tests (ALP 185 IU/l and ALT 21 IU/l) and coagulation profile were noted. These normalized prior discharge, whereas ultrasound scans showed no signs of liver failure or liver congestion.

Histology

Both pleural and pericardial biopsies showed non-specific inflammation and diffuse benign fibrosis. There were no features to suggest IgG4 disease.

Cardiac magnetic resonance imaging

There was an increase in the left ventricular/RV volume and decreased end-diastolic pressure when comparing the post-pericardiectomy with the preoperative cardiac MRI. There was marked reduction in thickening surrounding the heart postoperatively (Figure 1).

Cardiac magnetic resonance imaging. (A) Prepericardiectomy and (B) post-pericardiectomy. Arrow indicates marked reduction in pericardial thickening post-pericardiectomy.
Figure 1:

Cardiac magnetic resonance imaging. (A) Prepericardiectomy and (B) post-pericardiectomy. Arrow indicates marked reduction in pericardial thickening post-pericardiectomy.

DISCUSSION

The NICE guidelines state that the use of VA-ECMO in acute heart failure is adequately evidenced; however, there is uncertainty about which patients are likely to benefit from elective VA-ECMO [2]. The current limited evidence on safety shows a high incidence of serious complications [3, 5].

Some aspects are unique in this case: (i) the severe pectus excavatum, reducing the left thoracic volume; (ii) no histological evidence for IgG4-related disease and (iii) the use of VA-ECMO as elective adjunct for definitive surgery. In this case, VA-ECMO allowed the survival and recovery of the patient through the critical postoperative period, without the presence of significant right heart failure. This approach may be considered as a bridge and risk reduction strategy in patients at high risk of developing RV dysfunction following pericardiectomy. The implementation of this approach and threshold should be supported by further randomized controlled trials.

Conflict of interest: none declared.

REFERENCES

1

Busch
C
,
Penov
K
,
Amorim
PA
,
Garbade
J
,
Davierwala
P
,
Schuler
GC
et al.
Risk factors for mortality after pericardiectomy for chronic constrictive pericarditis in a large single-centre cohort
.
Eur J Cardiothorac Surg
2015
;
48
:
e110
16
.

2

Beckmann
E
,
Ismail
I
,
Cebotari
S
,
Busse
A
,
Martens
A
,
Shrestha
M
et al.
Right-sided heart failure and extracorporeal life support in patients undergoing pericardiectomy for constrictive pericarditis: a risk factor analysis for adverse outcome
.
Thorac Cardiovasc Surg
2017
;
65
:
662
70
.

3

Lafçı
G
,
Budak
A
,
Yener
A
,
Cicek
O.
Use of extracorporeal membrane oxygenation in adults
.
Heart Lung Circ
2014
;
23
:
10
23
.

4

Taghavi
S
,
Zuckermann
A
,
Ankersmit
J
,
Wieselthaler
G
,
Rajek
A
,
Laufer
G
et al.
Extracorporeal membrane oxygenation is superior to right ventricular assist device for acute right ventricular failure after heart transplantation
.
Ann Thorac Surg
2004
;
78
:
1644
9
.

5

Makdisi
G
,
Wangcorresponding
I.
Extra corporeal membrane oxygenation (ECMO) review of a lifesaving technology
.
J Thorac Dis
2015
;
7
:
E166
76
.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/journals/pages/open_access/funder_policies/chorus/standard_publication_model)